RTGC Stock Overview
Ridder Titan Genesis Corp., a medical marijuana company, focuses on the development of whole plant extractions for the cancer and palliative treatments.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Ridder Titan Genesis Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.50 |
52 Week High | US$1.00 |
52 Week Low | US$0.033 |
Beta | 0 |
1 Month Change | -17.00% |
3 Month Change | n/a |
1 Year Change | -33.60% |
3 Year Change | -38.52% |
5 Year Change | -28.10% |
Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
RTGC | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | -7.8% | -0.6% | 1.0% |
1Y | -33.6% | 10.6% | 21.9% |
Return vs Industry: RTGC underperformed the US Pharmaceuticals industry which returned 13.2% over the past year.
Return vs Market: RTGC underperformed the US Market which returned 24.9% over the past year.
Price Volatility
RTGC volatility | |
---|---|
RTGC Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 9.7% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: RTGC's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine RTGC's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1988 | n/a | Bruce Thompson | www.umfgroupinc.com |
Ridder Titan Genesis Corp., a medical marijuana company, focuses on the development of whole plant extractions for the cancer and palliative treatments. The company was formerly known as UMF Group Inc. and changed its name to Ridder Titan Genesis Corp. in February 2024. Ridder Titan Genesis Corp. was founded in 1988 and is based in Boulder, Colorado.
Ridder Titan Genesis Corp. Fundamentals Summary
RTGC fundamental statistics | |
---|---|
Market cap | US$3.33m |
Earnings (TTM) | US$4.71k |
Revenue (TTM) | US$140.97k |
0.0x
P/E Ratio0.0x
P/S RatioIs RTGC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
RTGC income statement (TTM) | |
---|---|
Revenue | US$140.97k |
Cost of Revenue | US$0 |
Gross Profit | US$140.97k |
Other Expenses | US$136.26k |
Earnings | US$4.71k |
Last Reported Earnings
Sep 30, 2011
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did RTGC perform over the long term?
See historical performance and comparison